Michael Ben Moshe

VP Finance, Corporate Treasury Teva Pharmaceuticals

Michael is the Vice President and Head of Global Working Capital & Cash Leadership Office at Teva Pharmaceutical Industries, the world's largest generic drug manufacturer. Bringing extensive expertise from the Pharmaceutical and Capital Markets industries, Michael plays a crucial role in overseeing Corporate Treasury activities at Teva. In his previous positions, he was leading Teva's Global Treasury Operations.

With a career spanning over 19 years, Michael has demonstrated leadership by guiding award-winning teams in implementing cutting-edge corporate finance and treasury methodologies. His diverse responsibilities include managing cash and liquidity, optimizing working capital, and mitigating financial risks within the treasury domain.

Throughout his career, Michael has successfully navigated complex tasks such as managing banking relationships, facilitating funding for major M&A transactions, optimizing the balance sheet, and executing asset divestitures. He has also played a key role in financing public offerings and spearheaded the optimization of internal cross-organizational processes to improve working capital efficiencies, fortify cash flow forecasting, and ensure liquidity.

Given Teva's intricate global operations, spanning 60 countries and involving 50 currencies, Michael's leadership within the Treasury team is instrumental in shaping and executing Teva's comprehensive financial strategy.

Agenda Day 1

2:25 PM CASE-STUDY PRESENTATION: Taking a seat at the table: How the treasury function can influence strategic decision making within a global corporation

As the role of a group treasurer continues to develop, far from being a purely operational group, treasurers have a critical role to play in all areas of company success. Successful delivery of the core treasury role can ensure dynamic risk management, provide fiscal stability for the organization and provide the right environment for corporate growth and expansion. However, whilst the role of a treasury group is undoubtedly vital to continued organizational success, the ability to demonstrate this value and exert a degree of influence on strategic decisions is often a challenge for those in this role.

 

In this case study presentation, Michael Ben Moshe of Teva Pharmaceuticals will give an insight into how his team have used a laser-sharp focus on cashflow and liquidity management to influence company direction. Far from being an operational delivery unity, the treasury team at Teva are central to many of the strategic direction of the company, and this session will focus on the journey taken and challenges overcome, to reach a point of being a trusted partner by the business 

2:50 PM INTERACTIVE PANEL DISCUSSION WITH AUDIENCE Q&A – How can a treasury group manage the impact of major company changes?

Treasury groups have a critical role in ensuring the successful delivery of many of the significant decisions taken by a business. Whether going through an IPO, purchasing a new company or going through a merger, or looking at ongoing business needs such as expansion or growth plans, the treasury team have to manage many of the processes inherent in ensuring the activity is successfully undertaken.


Bringing the treasury team into the decision-making process at an early stage is critical; indeed, activities such as purchases and mergers can potentially stall due to treasury integration challenges alone. As such, this panel discussion will aim to focus on the following:


  • How can treasury teams ensure their voice – and therefore needs – are heard BEFORE a fundamental business decision is taken?
  • What should the role of treasury be when advising on fundamental business change? Where should the influence extend to, and what is “out of scope”? How can this differ from company to company?
  • War stories and best practice – what practical advice can be given to help with ongoing change?

Check out the incredible speaker line-up to see who will be joining Michael.

Download The Latest Agenda